Adrenocortical carcinomas and adrenal pheochromocytomas: Mass and enhancement loss evaluation at delayed contrast-enhanced CT

Radiology

Volumn 234, Issue 2, 2005, Pages 479-485

  Szolar, Dieter H ^a   Korobkin, Melvyn ^b   Reittner, Pia ^a   Berghold, Andrea ^a   Bauernhofer, Thomas ^a   Trummer, Harald ^a   Schoellnast, Helmut ^a   Preidler, Klaus W ^a   Samonigg, Hellmuth ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IOHEXOL; IOPROMIDE;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL METASTASIS; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TUMOR VOLUME;

ADENOMA; ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADRENAL GLAND NEOPLASMS; ADRENOCORTICAL CARCINOMA; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 12344268844     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2342031876     Document Type: Article

References (26)

1. Dunnick NR, Korobkin M. Adrenal radiology: distinguishing benign from malignant adrenal masses. AJR Am J Roentgenol 1996; 167:861-867.
2. Lee MJ, Hahn PF, Papanlcolaou N, et al. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 1991; 179:415-418.
3. Korobkin M, Brodeur FJ, Yutzy GG, et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR Am J Roentgenol 1996; 166:531-536.
4. Mitchell DG, Crovello M, Matteucci T, Petersen RO, Miettinen MM. Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 1992; 185:345-351.
5. Korobkin M, Lombardi TJ, Aisen AM, et al. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology 1995; 197:411-418.
6. Korobkin M, Brodeur FJ, Francis IR, Quint LE, Dunnick NR, Goodsitt M. Delayed enhanced CT for differentiation of benign from malignant adrenal masses. Radiology 1996; 200:737-742.
7. Krestin GP, Friedmann G, Fishbach R, Neufang KF, Allolio B. Evaluation of adrenal masses in oncologic patients: dynamic contrast-enhanced MR vs CT. J Comput Assist Tomogr 1991; 15:104-110.
8. Outwater EK, Siegelmann ES, Huang AB, Birnbaum BA. Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences. Radiology 1996; 200:749-752.
9. Korobkin M, Brodeur FJ, Francis IR, Quint LE, Dunnick NR, Londy F. CT time-attenuation washout curves of adrenal adenomas and nonadenomas. AJR Am J Roentgenol 1998; 170:747-752.
10. Szolar DH, Kammerhuber FH. Quantitative CT evaluation of adrenal gland masses: a step forward in the differentiation between adenomas and nonadenomas. Radiology 1997; 202:517-521.
11. Szolar DH, Kammerhuber FH. Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT. Radiology 1998; 207:369-375.
12. Pena CS, Boland GW, Hahn PF, Lee MJ, Mueller PR. Characterization of indeterminate lipid-poor adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 2000; 217:798-802.
13. Caoili EM, Korobkin M, Francis IR, Cohan RH, Dunnick NR. Delayed enhanced CT of lipid-poor adrenal adenomas. AJR Am J Roentgenol 2000; 175:1411-1415.
14. Caoili EM, Korobkin M, Francis IR, et al. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 2002; 222:629-633.
15. Dunnick NR. Adrenal carcinoma. Radiol Clin North Am 1994; 32:99-108.
16. Francis IR, Korobkin M. Pheochromocytoma. Radiol Clin North Am 1996; 34: 1101-1112.
17. Korobkin M. CT characterization of adrenal masses: the time has come. Radiology 2000; 217:629-632.
18. Bilbey JH, McLoughlin RF, Kurkjian PS, et al. MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors. AJR Am J Roentgenol 1995; 164: 637-642.
19. Reinig JW, Stutley JE, Leonhardt CM, Spicer KM, Margolis M, Caldwell CB. Differentiation of adrenal masses with MR imaging: comparison of techniques. Radiology 1994; 192:41-46.
20. Gross MD, Saphiro B, Francis IR, et al. Scintigraphic evaluation of clinically silent adrenal masses. J Nucl Med 1994; 35:1145-1152.
21. Mayo-Smith WW, Boland GW, Noto RB, Lee MJ. State-of-the-art adrenal imaging. RadioGraphics 2001; 21:995-1012.
22. Glazer HS, Weyman PJ, Sagal SS, Levitt RG, McClennan BL. Adrenal masses: incident discovery on computed tomography. AJR Am J Roentgenol 1982; 139:81-85.
23. Korobkin M, Giordano TJ, Brodeur FJ, et al. Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 1996; 200:743-747.
24. Korobkin M, Francis IR. Adrenal imaging. Semin Ultrasound CT MR 1995; 16:317-330.
25. Oliver TW Jr, Bernardino ME, Miller JI, Mansour K, Greene D, Davis WA. Isolated adrenal masses in nonsmall-cell bronchogenic carcinoma. Radiology 1984; 153: 217-218.
26. Pagani JJ. Normal adrenal glands in small cell lung carcinoma: CT guided biopsy. AJR Am J Roentgenol 1983; 140:949-951.